ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $542,018 | -28.8% | 117,830 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $761,182 | -14.3% | 117,830 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $888,438 | -25.6% | 117,830 | 0.0% | 0.01% | -6.7% |
| Q4 2022 | $1,193,618 | +2.5% | 117,830 | 0.0% | 0.02% | +7.1% |
| Q3 2022 | $1,165,000 | -7.2% | 117,830 | 0.0% | 0.01% | -6.7% |
| Q2 2022 | $1,255,000 | -79.5% | 117,830 | -81.2% | 0.02% | -77.3% |
| Q1 2022 | $6,124,000 | +1122.4% | 628,130 | +2412.5% | 0.07% | +1220.0% |
| Q3 2021 | $501,000 | -58.6% | 25,000 | -54.5% | 0.01% | -58.3% |
| Q2 2021 | $1,210,000 | -10.9% | 55,000 | +37.5% | 0.01% | -7.7% |
| Q1 2021 | $1,358,000 | -80.7% | 40,000 | -77.1% | 0.01% | -83.1% |
| Q4 2020 | $7,042,000 | – | 175,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |